Veracyte Inc (VCYT)
35.02
+0.71
(+2.07%)
USD |
NASDAQ |
Nov 04, 16:00
35.70
+0.68
(+1.94%)
Pre-Market: 08:57
Veracyte Profit Margin (Quarterly): 5.01% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 5.01% |
March 31, 2024 | -1.92% |
December 31, 2023 | -28.81% |
September 30, 2023 | -32.87% |
June 30, 2023 | -9.30% |
March 31, 2023 | -9.82% |
December 31, 2022 | -4.79% |
September 30, 2022 | -11.54% |
June 30, 2022 | -13.08% |
March 31, 2022 | -21.33% |
December 31, 2021 | -15.64% |
September 30, 2021 | -23.40% |
June 30, 2021 | -16.40% |
March 31, 2021 | -114.1% |
December 31, 2020 | -23.29% |
September 30, 2020 | -13.25% |
June 30, 2020 | -53.25% |
March 31, 2020 | -37.65% |
December 31, 2019 | -25.09% |
September 30, 2019 | -2.36% |
June 30, 2019 | -8.28% |
March 31, 2019 | -6.49% |
December 31, 2018 | -12.06% |
September 30, 2018 | -19.04% |
Date | Value |
---|---|
June 30, 2018 | -27.46% |
March 31, 2018 | -45.79% |
December 31, 2017 | -43.06% |
September 30, 2017 | -40.24% |
June 30, 2017 | -39.65% |
March 31, 2017 | -50.01% |
December 31, 2016 | -24.12% |
September 30, 2016 | -30.30% |
June 30, 2016 | -76.61% |
March 31, 2016 | -74.35% |
December 31, 2015 | -57.06% |
September 30, 2015 | -72.52% |
June 30, 2015 | -76.72% |
March 31, 2015 | -67.84% |
December 31, 2014 | -66.74% |
September 30, 2014 | -80.32% |
June 30, 2014 | -76.70% |
March 31, 2014 | -89.27% |
December 31, 2013 | -86.17% |
September 30, 2013 | -112.7% |
June 30, 2013 | -128.1% |
March 31, 2013 | -157.3% |
December 31, 2012 | -108.5% |
September 30, 2012 | -153.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-114.1%
Minimum
Mar 2021
5.01%
Maximum
Jun 2024
-23.71%
Average
-16.40%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
Fonar Corp | 3.20% |
XWELL Inc | -21.50% |
ProPhase Labs Inc | -248.7% |
Applied DNA Sciences Inc | -- |
OncoCyte Corp | -4.36K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -4.97% |
Return on Assets | -4.63% |
Return on Invested Capital | -4.97% |
Gross Profit Margin (Quarterly) | 68.09% |
Operating Margin (Quarterly) | 4.33% |
Return on Net Operating Assets | -5.78% |